Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Follicle-stimulating hormone (FSH) and thyroid-stimulating hormone (TSH) second-messenger pathway is a critical signaling cascade primarily mediated by the cAMP/Protein Kinase A (PKA) system (StatPearls, 2023). Both FSH and TSH bind to their respective G protein-coupled receptors (FSHR and TSHR), which are coupled to the stimulatory G protein (Gs). Upon activation, the Gs alpha subunit stimulates adenylate cyclase, leading to an increase in intracellular cyclic AMP (cAMP) levels (UniProt P23945; UniProt P16473). This second messenger activates PKA, which subsequently phosphorylates downstream targets like the cAMP-response element-binding protein (CREB) to regulate genes involved in follicular growth, estrogen production, and thyroid hormone synthesis (PubMed, PMC6430617). Dysregulation of this pathway is implicated in conditions such as Graves' disease, where autoantibodies overstimulate the TSHR, and various forms of infertility or ovarian dysfunction (NIH, 2022). Therapeutic agents targeting this pathway include recombinant hormones like Follitropin and Thyrotropin alfa, which act as agonists to restore or stimulate physiological functions (PubChem).
Agonism of G protein-coupled receptors (FSHR and TSHR) to stimulate the Gs-adenylate cyclase-cAMP-PKA signaling cascade.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Follicle-stimulating hormone and thyroid-stimulating hormone second-messenger pathway.